Biophytis stock surges 32 % as COVID drug cuts risk of early death in
Biophytis (BPTS) said its medicine Sarconeos help cut the risk of early death or respiratory failure in patients with COVID-19 in a post-hoc analysis of a phase 2-3 trial.The company...
Source: seekingalpha.com